|Bid||0.000 x 0|
|Ask||0.750 x 0|
|Day's Range||0.450 - 0.475|
|52 Week Range||0.450 - 0.475|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Following the Effective Date, LIR expect to complete the transaction with Aura Health Corp. (the "Transaction") on or about August 9, 2018 and the resulting issuer's common shares (the "Shares") should be listed and begin to trade on the Canadian Securities Exchange on or about August 15, 2018 . The delisting has been approved by the majority of the minority of the Company's shareholders at the annual general and special meeting of the shareholders of the Company held on April 4, 2018 .
TORONTO , June 21, 2018 /CNW/ - Lamêlee Iron Ore Ltd. (LIR.V) ("LIR" or the "Company") announce that further to its news release dated June 1, 2018 , the Company has amended the terms of the securities exchange agreement dated May 31, 2018 (the "Securities Exchange Agreement") with Aura Health Corp. ("Aura") with respect to the proposed reverse-take-over transaction between the Company and Aura (the "RTO"). The RTO completion deadline has been extended from June 30, 2018 to July 31, 2018 , to allow Aura sufficient time to complete its previously announced private placement of a minimum $1,000,000 and a maximum of $5,000,000 financing (the "Private Placement", together with the RTO, the "Transaction").
TORONTO , June 1, 2018 /CNW/ - Lamêlee Iron Ore Ltd. (LIR.V) ("LIR" or the "Company") is pleased to announce that further to its news release dated January 24, 2018 the Company has received conditional approval from the Canadian Securities Exchange (the "CSE") for its listing application and entered into a definitive securities exchange agreement (the "Securities Exchange Agreement") effective May 31, 2018 , pursuant to which the Company will acquire (the "Acquisition") all of the issued and outstanding shares of Aura Health Corp. ("Aura"), from shareholders of Aura (the "Aura Shareholders"). Prior to, or concurrently with, the closing of the Acquisition, Aura will complete a private placement of a minimum $1,000,000 and a maximum of $5,000,000 at a targeted price of $1.00 per Aura security (the "Private Placement" and with the Acquisition, the "Transaction"). Final terms of the Aura Private Placement such as pricing, financing structure, commission and finder's or agent's fees will be subject to final approval by Aura, the CSE and/or other applicable regulatory authorities.
Lamelee Iron Ore Ltd. is pleased to announce that it has entered into a letter of intent dated January 23, 2018 with Aura Health Corp. whereby the parties will complete a business combination by way of ...
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2018) - The following issues have been halted by IIROC: Company: Lamelee Iron Ore Ltd. TSX-V Symbol: LIR (all ...
VANCOUVER , Jan. 24, 2018 /CNW/ - The following issues have been halted by IIROC: Company: Lamelee Iron Ore Ltd TSX-Venture Symbol: LIR (all issues) Reason: At the Request of the Company Pending News Halt ...
If you are looking to invest in Lamêlée Iron Ore Ltd’s (TSXV:LIR), or currently own the stock, then you need to understand its beta in order to understand how itRead More...